Document is current
Any future updates will be listed below
-
Authors
Slagle, Cara L.
Chmielewski, Jennifer L.
Rumpel, Jennifer A. https://orcid.org/0000-0002-5883-218X
Sanderson, Keia R.
Schuh, Meredith P. https://orcid.org/0000-0001-7854-8138
Starr, Michelle C. https://orcid.org/0000-0001-9412-8950
Segar, Jeffrey L. https://orcid.org/0000-0001-7311-8948
Ambalavanan, Namasivayam https://orcid.org/0000-0003-0731-9092
Askenazi, David
Selewski, David
Charlton, Jennifer R. https://orcid.org/0000-0002-2225-535X
Harer, Matthew W. https://orcid.org/0000-0001-5493-3269
,
Abitbol, Carolyn L.
Ahmad, Kaashif A.
Beck, Tara
Bignall, O. N. Ray II
Chaudhry, Paulomi
Condit, Paige E.
Deford, Amanda B.
DeFreitas, Marissa J.
Feeney, Alex
Fuhrman, Dana Y.
Gillen, Matthew C.
Gist, Katja
Gorga, Stephen M.
Guillet, Ronnie
Hanna, Mina
Isaac, Jaya S.
Jackson, Caroline V.
Jetton, Jennifer G.
Joseph, Catherine
Krawczeski, Catherine D.
Kwiatkowski, David M.
Laster, Marciana L.
Liberio, Brianna M.
Lowe, Kathryn J.
Marcuccilli, Morgan E.
Menon, Shina
Merrill, Kyle A.
Mohamed, Tahagod H.
Niemyjski, Emily A.
Obregon, Evelyn
Rademacher, Erin R.
Rajadhyaksha, Evan A.
Reidy, Kimberly J.
Schwartz, Samantha R.
Scott, Emily K.
Short, Kara C.
Soranno, Danielle E.
Steflik, Heidi J.
Stoops, Christine N.
Todukar, Namrata
Vuong, Kim T.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK136989)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P50DK096373)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R13DK137550)
- License Information
-
More Information
Article History
Received: 28 August 2025
Revised: 19 December 2025
Accepted: 9 February 2026
First Online: 26 February 2026
Competing interests
: All authors report no real or perceived conflicts of interest that could affect the study design, collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the manuscript for publication. For full disclosure, we provide the additional list of authors’ other funding not directly related to this study: Dr. Ambalavanan receives funding from NIH (R01HL157256; UG1HD107580; R01HD105205; R01HL156275; U44DA059380; RL1HD104251). Dr. Askenazi has consulted with Nuwellis, Seastar, and Abbott, and his institution has received funding for education and research from Nuwellis, Bioporto, Leadiant and Seastar. He has financial interests in patent/innovations pending in the area of kidney support therapies and urine collection devices. He is the Founder and Chief Scientific Officer for Zorro-Flow Inc. Dr. Charlton receives funding from the NIH (R01DK136989, P50DK096373-11, and Cystic Fibrosis Foundation), speaker for Mead Johnson and consultant to Mozarc Medical. Dr. Harer receives funding from NIH (UL1 TR002373 / KL2TR002374). Dr. Isaac receives funding from NIH (TL1DK136048). Dr. Fuhrman receives funding from NIH (K23DK116973). Dr. Laster receives funding from NIH (K23378), Dr. Reidy receives funding from the NIH, Dr. Rumple receives funding from the Arkansas Biosciences Institute, the National Center for Advancing Translational Sciences of the NIH (KL2TR003108), and the Marion B. Lyon New Scientist Development Award through the Arkansas Children’s Research Institute, Dr. Sanderson receives funding from NIH NIDDK (K23DK131289, L40DK130155), Dr. Schuh receives funding from NIH (5K08DK131259-02), Dr. Segar receives funding from NIH (R01DK133197; R01DK133121) and Medtronics, Dr. Soranno receives funding from NIH (R25HL163860), Dr. Starr receives funding from NIH (K23HL168362-01, R13DK137550-01), and Gerber Foundation. Dr. Slagle is a consultant for Bioporto and Mozarc Medical.
